Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy.

Sohyun HwangJaejoon LimHaeyoun KangJu-Yeon JeongJe-Gun JoungJinhyung HeoDaun JungKyunggi ChoHee Jung An

Published in: Cell & bioscience (2023)

We identified TNFRSF18, TNFSF4, and IL12RB2 as biomarkers that predict response to NK cell therapeutics in recurrent GBM, which might provide a new treatment strategy for this highly aggressive tumor.

Keyphrases

nk cells
single cell
cell therapy
small molecule
stem cells
mesenchymal stem cells
replacement therapy
smoking cessation